JTI Study: Nearly Half of British People are Aware of Illegal E-Cig Sale

Industry Insight by 2FIRSTS.ai
Feb.27.2024
JTI Study: Nearly Half of British People are Aware of Illegal E-Cig Sale
JTI study reveals high percentage of UK residents aware of illegal tobacco and e-cigarette sales, calling for stricter measures.

According to a report from the Bucksherald, a new study released by Japan Tobacco International (JTI) reveals that nearly half of British people are aware of illegal businesses selling smuggled tobacco (47%) and e-cigarettes (43%). The majority of British people (72%) believe that the cost of living crisis is causing smokers or vapers to seek cheaper illegal alternatives, leading to a vicious cycle that fuels organized crime and impacts local communities.

 

Another survey conducted by JTI showed that more than two-thirds of convenience stores (67%) also believe that the proposed intergenerational tobacco ban could lead to an increase in illicit tobacco activities, and are concerned that illegal products will become more prevalent.

 

According to the study, the research team has traveled to certain regions to conduct on-site investigations into the issue of illegal tobacco and e-cigarette sales. The results of the investigation revealed the extent of illegal tobacco sales in the UK, with West Yorkshire specifically experiencing a significant problem with illegal sales.

 

Regarding the public's perception of the organized crime risks that illegal tobacco and e-cigarette sales may pose to their local communities, nearly half of respondents (46%) believe the risks are "high" (29%) or "very high" (17%).

 

Popular measures to combat the illegal sale and distribution of tobacco and e-cigarettes include increasing fines for violators (59%), automatically revoking store licenses (also 59%), and automatically shutting down stores (44%).

 

Sarah Connor, director of communications for JTI UK, commented: "The illegal sale of tobacco and e-cigarettes is a major issue, causing significant negative impacts on communities. With tightening budgets for most people, and increasing taxes on legal tobacco and e-cigarette products, it is not surprising that more and more consumers are turning to illegal products as a cheaper alternative."

 

The company is calling for stronger cooperation between the government and the tobacco industry to prevent the sale of illicit tobacco and e-cigarettes.

 

According to a recent JTI survey conducted earlier this year in 2024, more than a quarter of retailers (28%) reported an increase in customers openly seeking illegal tobacco and e-cigarette products, while a quarter of retailers (26%) stated that their businesses have been negatively impacted due to other businesses in the community selling illegal tobacco and e-cigarettes.

 

Retailers believe that the main reason why 76% of retailers sell illegal tobacco or e-cigarette products is to boost sales, while customers are increasingly likely to purchase these illicit products because they are cheaper than legal alternatives.

 

Despite these findings, it is surprising that 95% of retailers reported that they have never reported a merchant selling illegal tobacco or e-cigarette products to the trade standards bureau.

 

Harsh punishments and fines, more frequent inspections from the trade standards agency, and stronger border controls to reduce the influx of illegal products into the UK are the most commonly cited solutions by retailers when discussing the support needed to address the issue of illegal tobacco.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Special Report|From CrossBar 20K to 6-Methyl Nicotine KUMI: Two Routes Into U.S. State Vape Directories?
Special Report|From CrossBar 20K to 6-Methyl Nicotine KUMI: Two Routes Into U.S. State Vape Directories?
Several U.S. states have incorporated the September 9, 2020 PMTA filing deadline into eligibility rules for certain vaping products. CrossBar 20K drew attention after appearing on Pennsylvania's 163-entry directory. A broader 2Firsts investigation found that related registration businesses also listed KUMI and CROSSBAR SIX products, with 171 KUMI-related entries across Louisiana, Nebraska and Wisconsin. Corporate records link Scott Silverman to Blue Nine LLC and VR Products I LLC. PMTA compliance expert Mr. K said historical applications and nicotine-analogue products may offer two different approaches to state-directory access.
Regulations
Oct.26
Australia Brings in Deloitte to Support Illicit Tobacco and Vape Enforcement Across Data, Processes and Project Delivery
Australia Brings in Deloitte to Support Illicit Tobacco and Vape Enforcement Across Data, Processes and Project Delivery
Australia’s Department of Home Affairs has hired Deloitte to provide data analytics, business-process, communications and project-delivery support to the Office of the Illicit Tobacco and E-Cigarette Commissioner. The government says Deloitte personnel do not provide policy advice to the Commissioner or the Australian government, with policy development and decision-making remaining with public officials. The arrangement has nevertheless drawn scrutiny because Deloitte has previously provided professional services to several tobacco and vaping companies.
Sep.03
Philippines Mandates Safety Certification for Nicotine Pouches, Gives Industry 12 Months to Comply
Philippines Mandates Safety Certification for Nicotine Pouches, Gives Industry 12 Months to Comply
The Philippines Department of Trade and Industry has placed nicotine pouches under mandatory product certification through Department Administrative Order No. 26-07, Series of 2026. Nicotine pouches must obtain a Philippine Standard, or PS, license before they can be manufactured, imported, packed, distributed or sold in the country. The regime requires testing for nicotine content, pH and water activity, while packaging must disclose nicotine strength, ingredients, allergens, batch information, the PS certification mark and prescribed health warnings. Existing market participants have a 12-month transition period to comply.
Regulations
Oct.12
UK Vape Duty Starts in October as Hayati, DOJO and Others Launch Lower-Capacity Products With Lower Per-Unit Tax
UK Vape Duty Starts in October as Hayati, DOJO and Others Launch Lower-Capacity Products With Lower Per-Unit Tax
The UK's Vaping Products Duty will take effect on October 1, 2026, at a flat rate of £2.20 per 10ml of vaping liquid. Ahead of implementation, DOJO, PIXL and Hayati have introduced or been reported to be adding lower-capacity tiers alongside larger products. DOJO has added a 6ml BLAST7K Fresh below its 10ml BLAST10K Fresh, PIXL offers both a 12ml 8000 and a 6ml 5K, while retailer Ninja Vapes says Hayati is preparing a 7ml 4K alongside its existing 12ml 6K. The pattern points to a growing lower-capacity tier in the UK market, although the brands have not all explicitly linked the changes to the new duty.
Sep.23
Russia’s Vape Device Labeling Regime Enters Force: Registration Starts in September, Mandatory Coding in December
Russia’s Vape Device Labeling Regime Enters Force: Registration Starts in September, Mandatory Coding in December
Russia's digital labeling regime for reusable e-cigarettes and similar personal vaping devices entered its first mandatory phase in September 2026. From September 1, manufacturers, importers and other market participants must register with the national Chestny ZNAK tracking system. From December 1, newly manufactured and imported covered devices will be required to carry digital identification codes and be reported as entering circulation. Russia has also issued new operational guidance for imports, marking the transition from a voluntary pilot to phased mandatory implementation.
Sep.15
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22